Bruker (BRKR) Depreciation & Amortization (CF) (2010 - 2026)
Bruker (BRKR) posted Depreciation & Amortization (CF) of $58.3 million for Q1 2026, little changed on a QoQ basis from $58.1 million in Q4 2025, and up 15.67% year-over-year from $50.4 million in Q1 2025.
Bruker (BRKR) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Bruker's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $58.3 million for Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 15.67% year-over-year to $58.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $228.2 million (up 14.44% YoY) and the FY2025 annual result came in at $220.3 million, up 19.86% from the prior year.
- Depreciation & Amortization (CF) was $58.3 million for Q1 2026 at Bruker, roughly flat from $58.1 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $58.3 million in Q1 2026 and bottomed at $21.0 million in Q3 2022.
- A 5-year average of $39.2 million and a median of $37.3 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) retreated 5.41% — and 2024, when it surged 91.73%.
- Bruker's Depreciation & Amortization (CF) stood at $24.5 million in 2022, then surged by 52.24% to $37.3 million in 2023, then jumped by 41.82% to $52.9 million in 2024, then climbed by 9.83% to $58.1 million in 2025, then climbed by 0.34% to $58.3 million in 2026.
- Business Quant data shows BRKR's Depreciation & Amortization (CF) at $58.3 million in Q1 2026, $58.1 million in Q4 2025, and $55.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bruker | 9.46 Bn | 9.50 Bn | 379.80 Mn | 58.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.30 Mn |
| Mar 31, 2026 | 58.30 Mn |
| Dec 31, 2025 | 58.10 Mn |
| Dec 31, 2025 | 58.10 Mn |
| Sep 30, 2025 | 55.70 Mn |
| Sep 30, 2025 | 55.70 Mn |
| Jun 30, 2025 | 56.10 Mn |
| Jun 30, 2025 | 56.10 Mn |
| Mar 31, 2025 | 50.40 Mn |
| Mar 31, 2025 | 50.40 Mn |
| Dec 31, 2024 | 52.90 Mn |
| Dec 31, 2024 | 52.90 Mn |
| Sep 30, 2024 | 51.00 Mn |
| Sep 30, 2024 | 51.00 Mn |
| Jun 30, 2024 | 45.10 Mn |
| Jun 30, 2024 | 45.10 Mn |
| Mar 31, 2024 | 34.70 Mn |
| Mar 31, 2024 | 34.70 Mn |
| Dec 31, 2023 | 37.30 Mn |
| Dec 31, 2023 | 37.30 Mn |